Skip to main content

Sage Therapeutics, Inc.

SAGEDelisted Jul 31, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597553

Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Sage Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of SAGE: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders202206+4
Shares56.1M58.5M+2.38M (+4.2%)
Value$1.22B$1.10B−$118.9M (−9.8%)

New holders (28)

Institutions that held Sage Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to SAGE in Q1 2024
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.641,211$12.0M0.03%
Baker Bros. Advisors LP407,217$7.63M0.10%
Soros Fund Management LLCSuperinvestorSoros Fund Management275,000$5.15M0.12%
683 Capital Management, LLC200,000$3.75M0.38%
Granahan Investment Management Inc156,371$2.93M0.10%
Woodline Partners LP104,831$1.96M0.02%
CIBC World Markets Corp100,000$1.87M0.01%
HSBC Holdings PLC83,577$1.57M0.00%
Campbell & CO Investment Adviser LLC49,274$923.4K0.08%
Squarepoint Ops LLC44,858$840.6K0.00%
Renaissance Technologies LLC35,100$658.0K0.00%
New York Life Investment Management LLC19,151$358.9K0.00%
Prudential Financial Inc16,075$301.2K0.00%
Axq Capital, LP10,570$198.1K0.05%
Sherbrooke Park Advisers LLC10,058$188.5K0.04%
Virtu Financial LLC10,003$187.0K0.01%
Lazard Asset Management LLC6,825$127.0K0.00%
Danske Bank A/S3,434$64.4K0.00%
Pacer Advisors, Inc.1,826$34.2K0.00%
Catalyst Funds Management Pty Ltd1,600$30.0K0.01%
Headlands Technologies LLC1,134$21.3K0.01%
nVerses Capital, LLC400$7.50K0.02%
Point72 Asia (Singapore) Pte. Ltd.395$7.40K0.00%
Fernwood Investment Management, LLC169$3.17K0.00%
Cutler Group LP200$3.00K0.00%
CIBC Private Wealth Group, LLC140$2.51K0.00%
Continuum Advisory, LLC50$6170.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC10$1870.00%

Sold out (24)

Institutions that held Sage Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.